The Ca2+/CaM, Src kinase and/or PI3K-dependent EGFR transactivation via 5-HT2A and 5-HT1B receptor subtypes mediates 5-HT-induced vasoconstriction

Community Guidelines for GPCR Ligand Bias: IUPHAR Review XX

(2022) Peter Kolb et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)

(2020) Tao Guo et al.   JAMA Cardiology

Platelets Can Associate with SARS-Cov-2 RNA and Are Hyperactivated in COVID-19

(2020) Younes Zaid et al.   CIRCULATION RESEARCH

Inverse agonists of the 5-HT2A receptor reduce nicotine withdrawal signs in rats

(2019) David Malin et al.   NEUROSCIENCE LETTERS

KV channels and the regulation of vascular smooth muscle tone

(2018) William F. Jackson   MICROCIRCULATION

Epidermal Growth Factor Receptor Transactivation: Mechanisms, Pathophysiology, and Potential Therapies in the Cardiovascular System

(2016) Steven J. Forrester et al.   Annual Review of Pharmacology and Toxicology

c-Src Inhibition Improves Cardiovascular Function but not Remodeling or Fibrosis in Angiotensin II–Induced HypertensionNovelty and Significance

(2016) Glaucia E. Callera et al.   HYPERTENSION

Role of Epidermal Growth Factor Receptor and Endoplasmic Reticulum Stress in Vascular Remodeling Induced by Angiotensin IINovelty and Significance

(2015) Takehiko Takayanagi et al.   HYPERTENSION

Consequences of Epidermal Growth Factor Receptor (ErbB1) Loss for Vascular Smooth Muscle Cells From Mice With Targeted Deletion of ErbB1

(2011) Barbara Schreier et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

α1-Adrenoceptor-mediated contraction of rat aorta is partly mediated via transactivation of the epidermal growth factor receptor

(2010) N Ulu et al.   BRITISH JOURNAL OF PHARMACOLOGY

GPCR agonist-induced transactivation of the EGFR upregulates MLC II expression and promotes hypertension in insulin-resistant rats

(2010) Prabhakara Reddy Nagareddy et al.   CARDIOVASCULAR RESEARCH

Calmodulin-mediated regulation of the epidermal growth factor receptor

(2009) Pablo Sánchez-González et al.   FEBS Journal

The existence of a local 5-hydroxytryptaminergic system in peripheral arteries

(2008) W Ni et al.   BRITISH JOURNAL OF PHARMACOLOGY

Phosphoinositide 3-kinase signalling in the vascular system

(2008) F. Morello et al.   CARDIOVASCULAR RESEARCH

Elevated Epidermal Growth Factor Receptor Phosphorylation Induces Resistance Artery Dysfunction in Diabetic db/db Mice

(2008) S. Belmadani et al.   DIABETES

Serotonin 5-Hydroxytryptamine2A Receptor Activation Suppresses Tumor Necrosis Factor- -Induced Inflammation with Extraordinary Potency

(2008) B. Yu et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

c-Src tyrosine kinase, a critical component for 5-HT2Areceptor-mediated contraction in rat aorta

(2008) Rong Lu et al.   JOURNAL OF PHYSIOLOGY-LONDON